$同源康医药-B(0_老虎社区_美港股上老虎

$同源康医药-B(02410)$ 在目前国内全链条支持创新药发展的政策环境下，同源康的艾多替尼有望凭借自身差异化创新力为后续产品商业化预期奠定扎实基础

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":501609248420752,"tweetId":"501609248420752","gmtCreate":1763471246006,"gmtModify":1763471248172,"author":{"id":4214049281636630,"idStr":"4214049281636630","authorId":4214049281636630,"authorIdStr":"4214049281636630","name":"永远的话事人","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 在目前国内全链条支持创新药发展的政策环境下，同源康的艾多替尼有望凭借自身差异化创新力为后续产品商业化预期奠定扎实基础</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 在目前国内全链条支持创新药发展的政策环境下，同源康的艾多替尼有望凭借自身差异化创新力为后续产品商业化预期奠定扎实基础</p></body></html>","text":"$同源康医药-B(02410)$ 在目前国内全链条支持创新药发展的政策环境下，同源康的艾多替尼有望凭借自身差异化创新力为后续产品商业化预期奠定扎实基础","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/501609248420752","repostId":0,"isVote":1,"tweetType":1,"viewCount":61,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02410"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":136,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}